Prednisolone/Prednisone ( DrugBank: Prednisone, Prednisolone )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
49全身性エリテマトーデス1

49. 全身性エリテマトーデス


臨床試験数 : 993 薬物数 : 702 - (DrugBank : 184) / 標的遺伝子数 : 116 - 標的パスウェイ数 : 200
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01085097
(ClinicalTrials.gov)
September 1, 20104/3/2010A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus NephritisA Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)Lupus NephritisDrug: Laquinimod;Drug: Mycophenolate Mofetil;Drug: Prednisolone/Prednisone;Drug: Placebo;Drug: MethylprednisoloneTeva Branded Pharmaceutical Products R&D, Inc.NULLCompleted18 Years75 YearsAll46Phase 2United States;Canada;France;Russian Federation;United Kingdom